Extended thromboprophylaxis in hospitalised patients with cancer does not reduced the rate of venous thromboembolic (VTE) events and is associated with increased risk of haemorrhage, a systematic review has found. While the use of extended (28-42 days) thromboprophylaxis after hospitalisation has previously been shown to have benefit over standard-duration (14 days) thromboprophylaxis, this was not ...
Extended thromboprophylaxis does not reduce VTE in hospitalised cancer patients
By Michael Woodhead
28 Jun 2021